Researchers from the Dana-Farber Cancer Institute have identified a glucose metabolism pathway that is activated by the K-Ras oncogene in pancreatic cancer. Based on the findings, it may be possible to target proteins in the pathway to block proliferation of K-Ras-driven cancers